2024

• Tiong, I., Wall, M., Bajel, A., Kalro, A., Fleming, S., Roberts, A., Thiagarajah, N., Chua, C., Latimer, M., Yeung, D., Stevenson, W., et al (2024). How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? Blood Cancer Journal, 14(1). [More Information]

2023

• Cashion, C., Bonnitcha, P., Stevenson, W. (2023). Acute onset severe hypophosphataemia in transformed acute myeloid leukaemia: an unusual biochemical presentation. Journal of Clinical Pathology, , jcp-2023-208907. [More Information]
• Blennerhassett, R., Othman, J., Biscoe, A., Kliman, D., Mills, G., Blyth, E., Micklethwaite, K., Kwan, J., Bilmon, I., Bhattacharyya, A., Stevenson, W., Greenwood, M., Gottlieb, D., Kerridge, I., et al (2023). Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis. Internal Medicine Journal. [More Information]

2022

• Hsu, H., Chan, M., Armstrong, P., Crescente, M., Donikian, D., Kondo, M., Brighton, T., Chen, V., Chen, Q., Connor, D., Morel-Kopp, M., Stevenson, W., Ward, C., Rabbolini, D., et al (2022). A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia. Pathology, 54(6), 746-754. [More Information]
• Rabbolini, D., Liang, H., Morel-Kopp, M., Connor, D., Whittaker, S., Dunkley, S., Donikian, D., Kondo, M., Chen, W., Stevenson, W., Campbell, H., Ward, C., Chen, V., et al (2022). Building platelet phenotypes: diaphanous-related formin 1 (DIAPH1)-related disorder. Platelets, 33(3), 432-442. [More Information]
• Ewans, L., Minoche, A., Schofield, D., Shrestha, R., Puttick, C., Zhu, Y., Drew, A., Gayevskiy, V., Elakis, G., Walsh, C., Ades, L., Ellaway, C., Stevenson, W., Wilson, M., Morel-Kopp, M., et al (2022). Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis. European Journal of Human Genetics, 30(10), 1121-1131. [More Information]

2021

• Lindsay, J., Othman, J., Kerridge, I., Fay, K., Stevenson, W., Arthur, C., Chen, S., Kong, D., Pergam, S., Liu, C., Greenwood, M., et al (2021). Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance. Transplant Infectious Disease, 23(3). [More Information]
• Lindsay, J., Othman, J., Yong, M., Ritchie, D., Chee, L., Tay, K., Tio, S., Kerridge, I., Fay, K., Stevenson, W., Greenwood, M., et al (2021). Dynamics of Epstein–Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant. Transplant Infectious Disease, 23(5), e13719. [More Information]
• Gifford, G., Hesson, L., Wong, J., Carroll, A., Gabrielli, S., Bai, L., Xia, W., Stevenson, W., Greenwood, M. (2021). Poor mobilization of autologous CD34+ peripheral blood stem cells in haematology patients undergoing autologous stem cell transplantation is associated with the presence of variants in genes implicated in clonal haematopoiesis of indeterminant potential. British Journal of Haematology, 193(4), 841-844. [More Information]
• Lindsay, J., Othman, J., Kong, Y., Yip, A., van Hal, S., Larsen, S., Bryant, C., Gibson, J., Kerridge, I., Fay, K., Stevenson, W., Chen, S., Greenwood, M., et al (2021). SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases, 8(11). [More Information]

2020

• Stevenson, W., Bryant, J., Watson, R., Sanson-Fisher, R., Oldmeadow, C., Henskens, F., Brown, C., Ramanathan, S., Tiley, C., Enjeti, A., et al (2020). A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons. Journal of Psychosocial Oncology, 38(3), 272-292. [More Information]
• Rabbolini, D., Connor, D., Morel-Kopp, M., Donikian, D., Kondo, M., Chen, W., Alessi, M., Stevenson, W., Chen, V., Joseph, J., Ward, C., et al (2020). An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet Group. Pathology, 52(2), 243-255. [More Information]
• Gifford, G., Stevenson, W., Best, G. (2020). Combination of the dual PIM/PI3-kinase inhibitor IBL-202 and venetoclax is effective in diffuse large B-cell lymphoma. Leukemia & Lymphoma, 61(13), 3165-3176. [More Information]
• Gifford, G., Gifford, A., Chen, Q., Shen, Y., Gabrielli, S., Gill, A., Stevenson, W., Best, G. (2020). Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma. Leukemia & Lymphoma, 61(8), 1810-1822. [More Information]
• Keane, C., Law, S., Gould, C., Birch, S., Sabdia, M., de Long, L., Thillaiyampalam, G., Abro, E., Tobin, J., Tan, X., Gifford, G., Gabreilli, S., Stevenson, W., et al (2020). LAG3: A novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma. Blood Advances, 4(7), 1367-1377. [More Information]
• Lwin, Y., Lindsay, J., Reid, C., Wong, K., Kerridge, I., Arthur, C., Fay, K., Stevenson, W., Greenwood, M. (2020). Oral fludarabine is an effective and convenient alternative to intravenous fludarabine in fludarabine melphalan based reduced intensity conditioning regimens. Bone Marrow Transplantation, 55, 1638-1641. [More Information]
• Arthur, C., Jeffrey, A., Yip, E., Katsioulas, V., Nalpantidis, A., Kerridge, I., Greenwood, M., Coyle, L., Mackinlay, N., Fay, K., Stevenson, W., et al (2020). Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. Leukemia & Lymphoma, 61(4), 831-839. [More Information]
• Othman, J., Greenwood, M., Moore, J., Larsen, S., Watson, A., Arthur, C., Bhattacharyya, A., Bilmon, I., Blyth, E., Bryant, A., Gibson, J., Kerridge, I., Stevenson, W., Gottlieb, D., et al (2020). Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG. Biology of Blood and Marrow Transplantation, 26(10), 1868-1875. [More Information]

2019

• Carr, F., Tan, K., Stevenson, W., Ahmad, K. (2019). A Case of Acute Myeloid Leukaemia Presenting as Subacute Intracranial Hypertension in a Young Adult. Neuro-Ophthalmology, 43(5), 313-317. [More Information]
• Colm, K., Tobin, J., Gunawardana, J., Francis, S., Gifford, G., Gabrielli, S., Gill, A., Stevenson, W., Talaulikar, D., Gould, C., et al (2019). The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B-Cell Lymphoma. European Journal of Haematology, 103(3), 200-207. [More Information]

2018

• Rabbolini, D., Chun, Y., Latimer, M., Kunishima, S., Fixter, K., Valecha, B., Tan, P., Chew, L., Kile, B., Burt, R., Gabrielli, S., Chen, Q., Stevenson, W., Ward, C., Morel-Kopp, M., et al (2018). Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia. Platelets, 29(8), 793-800. [More Information]
• Stein, A., Larson, R., Schuh, A., Stevenson, W., Lech-Maranda, E., Tran, Q., Zimmerman, Z., Kormany, W., Topp, M. (2018). Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia. Blood Advances, 2(13), 1522-1531. [More Information]
• Crassini, K., Zhang, E., Balendran, S., Freeman, J., Best, G., Forsyth, C., MacKinlay, N., Han, P., Stevenson, W., Mulligan, S. (2018). Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia. British Journal of Haematology, 181(1), 97-101. [More Information]
• Gifford, G., Gabrielli, S., Gill, A., Greenwood, M., Wong, K., Best, G., Nevell, D., Mcilroy, K., Kliman, D., Ilmay-Gillespie, L., Stevenson, W., et al (2018). Lymphoma cell-of–origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts. British Journal of Haematology, 181(2), 272-275. [More Information]
• Fixter, K., Rabbolini, D., Valecha, B., Morel-Kopp, M., Gabrielli, S., Chen, Q., Stevenson, W., Ward, C. (2018). Mean platelet diameter measurements to classify inherited thrombocytopenias. International Journal of Laboratory Hematology, 40(2), 187-195. [More Information]
• Crassini, K., Shen, Y., Ward, C., Christopherson, R., Mulligan, S., Best, G., Stevenson, W. (2018). MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment. British Journal of Haematology, 182(3), 360-372. [More Information]
• Cui, W., Stern, C., Hickey, M., Goldblatt, F., Anazodo, A., Stevenson, W., Phillips, K. (2018). Preventing ovarian failure associated with chemotherapy. Medical Journal of Australia, 209(9), 412-416. [More Information]
• Mundell, S., Rabbolini, D., Gabrielli, S., Chen, Q., Aungraheeta, R., Hutchinson, J., Kilo, T., Mackay, J., Ward, C., Stevenson, W., Morel-Kopp, M. (2018). Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding. Journal of Thrombosis and Haemostasis, 16(1), 44-53. [More Information]

2017

• Rabbolini, D., Gardiner, E., Morel-Kopp, M., Dunkley, S., Jahangiri, A., Lee, C., Stevenson, W., Ward, C. (2017). Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity? Research and Practice in Thrombosis and Haemostasis, 1(2), 291-295. [More Information]
• Douglas, G., Harrison, C., Forsyth, C., Bennett, M., Stevenson, W., Hounsell, J., Ratnasingam, S., Ritchie, D., Ross, D., Grigg, A. (2017). Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. Leukemia and Lymphoma, 58(1), 89-95. [More Information]
• Rabbolini, D., Morel-Kopp, M., Ward, C., Stevenson, W. (2017). GFI1B variants associated with thrombocytopenia. Platelets, 28(5), 525-527. [More Information]
• Lindsay, J., Sandaradura, I., Wong, K., Arthur, C., Stevenson, W., Kerridge, I., Fay, K., Coyle, L., Greenwood, M. (2017). Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation. Journal of Antimicrobial Chemotherapy, 72(12), 3414-3419. [More Information]
• Rabbolini, D., Morel-Kopp, M., Chen, Q., Gabrielli, S., Dunlop, L., Chew, L., Blair, N., Brighton, T., Singh, N., Ng, A., Ward, C., Stevenson, W. (2017). Thrombocytopenia and CD34 expression is decoupled from (alpha)-granule deficiency with mutation of the first growth factor-independent 1B zinc finger. Journal of Thrombosis and Haemostasis, 15(11), 2245-2258. [More Information]

2016

• Simeoni, I., Stephens, J., Hu, F., Deevi, S., Megy, K., Bariana, T., Lentaigne, C., Schulman, S., Stevenson, W., et al (2016). A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood, 127(23), 2791-2803. [More Information]
• Gifford, G., Gill, A., Stevenson, W. (2016). Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists. Pathology, 48(1), 5-16. [More Information]
• Andrici, J., Farzin, M., Clarkson, A., Sioson, L., Sheen, A., Watson, N., Toon, C., Koleth, M., Stevenson, W., Gill, A. (2016). Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms. Pathology, 48(4), 319-324. [More Information]

2015

• Gifford, G., Wong, K., Kerridge, I., Stevenson, W., Arthur, C., Fay, K., Greenwood, M. (2015). Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high-risk acute myeloid leukaemia and other high risk myeloid malignancies. American Journal Of Hematology, 90(5), e97-e100. [More Information]
• Lynagh, M., Clinton-Mcharg, T., Hall, A., Sanson-Fisher, R., Stevenson, W., Tiley, C., Bisquera, A. (2015). Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Experimental Hematology & Oncology, 4, 1-8. [More Information]
• Rabbolini, D., Morel-Kopp, M., Gabrielli, S., Chen, Q., Stevenson, W., Ward, C. (2015). DNA-based Diagnosis of Uncharacterized Inherited Macrothrombocytopenias Using Next-generation Sequencing Technology with a Candidate Gene Array. In Jerzy K Kulski (Eds.), Next Generation Sequencing: Advances, Applications and Challenges, (pp. 387-408). Rijeka, Croatia: InTech Publishers. [More Information]
• Wei, A., Tan, P., Perruzza, S., Govindaraj, C., Fleming, S., Macmanus, J., Avery, S., Patil, S., Stevenson, W., Plebanski, M., et al (2015). Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia. British Journal of Haematology, 169(2), 199-210. [More Information]
• Stevenson, W., Rabbolini, D., Beutler, L., Chen, Q., Gabrielli, S., Mackay, J., Brighton, T., Ward, C., Morel-Kopp, M. (2015). Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1. Blood, 126(17), 2027-2030. [More Information]
• Stevenson, W., Morel-Kopp, M., Ward, C. (2015). Platelets are not all gray in GFI1B disease. Clinical Genetics, 87(3), 299-299. [More Information]
• Ho, P., Marlton, P., Tam, C., Stevenson, W., Ritchie, D., Bird, R., Dunlop, L., Durrant, S., Ross, D. (2015). Practical management of myelofibrosis with ruxolitinib. Internal Medicine Journal, 45(12), 1221-1230. [More Information]
• Bryant, J., Sanson-Fisher, R., Stevenson, W., Smits, R., Henskens, F., Wei, A., Tzelepis, F., D'Este, C., Paul, C., Carey, M. (2015). Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons. BMC Cancer, 15(1), 1-13. [More Information]
• Estecio, M., Madipoti, S., Bueso-Ramos, C., DiNardo, C., Yang, H., Wei, Y., Kondo, K., Fang, Z., Stevenson, W., Chang, K., et al (2015). RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. British Journal of Haematology, 169(3), 344-351. [More Information]
• Crassini, K., Stevenson, W., Mulligan, S., Best, O. (2015). The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. Leukemia & Lymphoma, 56(12), 3407-3417. [More Information]

2014

• Stevenson, W., Best, G., Przybylla, A., Chen, Q., Singh, N., Koleth, M., Pierce, S., Kennedy, T., Tong, W., Kuang, S., et al (2014). DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukemia. Leukemia, 28(4), 787-793. [More Information]
• Rabbolini, D., Morel-Kopp, M., Stevenson, W., Ward, C. (2014). Inherited Macrothrombocytopenias. Seminars in Thrombosis and Hemostasis, 40(7), 774-784. [More Information]
• Smits, R., Bryant, J., Sanson-Fisher, R., Tzelepis, F., Henskens, F., Paul, C., Stevenson, W. (2014). Tailored and Integrated Web-Based Tools for Improving Psychosocial Outcomes of Cancer Patients: The DoTTI Development Framework. Journal of Medical Internet Research, 16(3), 1-17. [More Information]

2013

• Stevenson, W., Morel-Kopp, M., Chen, Q., Liang, H., Bromhead, C., Wright, S., Turakulov, R., Ng, A., Roberts, A., Bahlo, M., Ward, C. (2013). GFI1B mutation causes a bleeding disorder with abnormal platelet function. Journal of Thrombosis and Haemostasis, 11(11), 2039-2047. [More Information]
• Freeman, J., Crassini, K., Best, G., Forsyth, C., MacKinlay, N., Han, P., Stevenson, W., Mulligan, S. (2013). Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leukemia & Lymphoma, 54(1), 99-104. [More Information]
• Singh, N., Morris, C., Koleth, M., Wong, K., Ward, C., Stevenson, W. (2013). Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease. Molecular Cytogenetics, 6(1), 1-12. [More Information]

2012

• Hain, S., Khan, S., Stevenson, W. (2012). 18F-FDG PET to identify soft tissue disease in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 39(3), 553-554. [More Information]

2010

• Dayyani, F., Conley, A., Strom, S., Stevenson, W., Cortes, J., Borthakur, G., Faderl, S., O'Brien, S., Pierce, S., Kantarjian, H., et al (2010). Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer, 116(9), 2174-2179. [More Information]
• Stevenson, W., Hyland, C., Zhang, J., Morgan, P., Wilson, T., Gill, A., Hilton, A., Viney, E., Bahlo, M., Masters, S., et al (2010). Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice. Proceedings of the National Academy of Sciences of the United States of America, 107(38), 16625-16630. [More Information]
• Tong, W., Wei, Y., Stevenson, W., Kuang, S., Fang, Z., Zhang, M., Arts, J., Garcia-Manero, G. (2010). Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor. Leukemia Research: clinical and laboratory studies, 34(2), 221-228. [More Information]

2005

• Stevenson, W., Nankivell (Nankievell), B., Hertzberg, M. (2005). Nephrotic syndrome after stem cell transplantation. Clinical Transplantation, 19(1), 141-144. [More Information]